Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

P&U develops antidiabetic amino- and diaminoguanidines

March 31, 1998

FDA clears pravastatin for stroke prevention

March 31, 1998

IND filed for tissue-selective estrogen compound

March 30, 1998

FDA approves Viagra; first oral treatment for ED on the way to market

March 30, 1998

Focus on agents for estrogen deprivation continues at Lilly

March 30, 1998

SKB develops new agents for osteoporosis and related disorders

March 30, 1998

Cytokine inhibitors claimed by Novo Nordisk for diabetes and other disorders

March 30, 1998

Senetek will present additional INVICORP clinical data at AUA annual meeting

March 30, 1998

Combination therapy incorporating troglitazone leads to efficient control of type II diabetes

March 27, 1998

Second patent issues to Zonagen for Vasomax

March 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...